Factors associated with arterial hypertension in pharmacy users in Portugal;Factores associados à hipertensão arterial nos utentes de farmácias em Portugal

Revista de Saude Publica

Volumn 45, Issue 1, 2011, Pages 136-144

  de Oliveira Martins, Sofia ^a   Oliveira, Tiago ^b   Gomes, João J F ^c   Caramona, Margarida ^d   Cabrita, José ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b NOVA INFORMATION MANAGEMENT SCHOOL NOVA IMS   (Portugal)

^c UNIVERSITY OF LISBON   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Cross sectional studies; Hypertension, epidemiology; Pharmacies, utilization; Risk factors

Indexed keywords

EID: 78650443668     PISSN: 00348910     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0034-89102011000100022     Document Type: Article

References (20)

1. Broad J, Wells S, Marshall R, Jackson R. Zero enddigit preference in recorded blood pressure and its impact on classification of patients for pharmacologic management in primary care - PREDICTCVD-6. Br J Gen Pract. 2007;57(544):897-903. DOI:10.3399/096016407782317964.
2. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menottia, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24(11):987-1003. DOI:10.1016/S0195-668X(03)00114-3.
3. Correia M, Silva MR, Matos I, Magalhães R, Lopes IC, Ferro JM, et al. Prospective Community-based study of stroke in northern Portugal. Incidence and case fatality in rural and urban populations. Stroke. 2004;35(9):2048-53. DOI:10.1161/01.STR.0000137606.34301.13.
4. Costa J, Borges M, Oliveira E, Gouveia M, Vaz Carneiro A. Incidência e prevalência da hipercolesterolémia em Portugal: uma revisão sistemática da literatura. Parte II. Rev Port Cardiol. 2003;22(5):683-702.
5. European Society of Cardiology. European Guidelines of Cardiovascular Prevention in clinical Pratice. Eur J Cardiovasc Prev Rehabil. 2003;10:1-78.
6. Esposti ED, Martino MD, Sturani A, Russo P, Dradi, C, Falcinelli S, et al. Risk factors for uncontrolled hypertension in Italy. J Hum Hypertens. 2004;18(3):207-13. DOI:10.1038/sj.jhh.1001656.
7. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: Willey; 2000.
8. Joffres MR, Ghadirian P, Fodor JG, Petrasovits A, Chockalingam A, Hamet P. Awareness, treatment and control of Hypertension in Canada. Am J Hypertens. 1997;10(10):1097-102. DOI:10.1016/S0895-7061(97)00224-0.
9. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217-23.
10. Knight, EL, Bohn RL, Wang PS, Glynn RJ, Mogun H, Avorn J. Predictors of uncontrolled hypertension in ambulatory patients. Hypertension. 2001;38(4):809-14. DOI:10.1161/hy0901.091681.
11. Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart. 2002;88(2):119-124. DOI:10.1136/heart.88.2.119.
12. Lunet N, Barros H. Gender differences in the treatment of hypertension: a Community based study in Porto. Rev Port Cardiol. 2002;21(1):7-19.
13. Macedo ME, Lima MJ, Silva AO, Alcântara P, Ramalhinho V, Carmona J. Prevalence, Awareness, Treatment and Control of Hypertension in Portugal. The PAP study. J Hypertens. 2005;23(9):1661-6. DOI:10.1097/01.hjh.0000179908.51187.de.
14. Rodrigues M, Noronha MM, Vieira-Dias M, Lourenço S, Santos-Bento M, Fernandes H, Reis F, Machado-Cândido J. Stroke in Europe: where is Portugal? POPBASIS 2000 Study. Cerebrovasc Dis. 2002;13(Suppl 3):72.
15. Santos AC, Barros H. Prevalence and determinants of obesity in an urban sample of Portuguese adults. Public Health. 2003;117(6):430-7. DOI:10.1016/S0033-3506(03)00139-2.
16. Scheltens T, Bots ML, Numans ME, Grobbee DE, Hoes AW. Awareness, treatment and control of hypertension: the "rule of halves" in an area of risk-based treatment of hypertension. J Hum Hypertens. 2007;21(2):99-106. DOI:10.1038/sj.jhh.1002123.
17. Sehestedt T, Ibsen H, Jorgensen T. Awareness, treatment and control of hypertension in Denmark. The Inter99 Study. Blood Pressure. 2007;16(5):312-9. DOI:10.1080/08037050701428307.
18. Smits N, Smit F, Cuijpers P, De Graaf R. Using decision theory to derive optimal cut-off scores of screening instruments: an illustration explicating costs and benefits of mental health screening. Int J Methods Psychiatr Res. 2007;16(4):219-29. DOI:10.1002/mpr.230.
19. Whitworth JA, World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21(11):1983-92. DOI:10.1097/00004872-200311000-00002.
20. World Health Organization. World Health Report 2002: reducing risks, promoting healthy life. Geneva; 2002.